tirzepatide head to head semaglutide SURPASS-2 (NEJM 2021) was the definitive head-to-head: vs 1.0 mg (the maximum approved T2DM dose) in 1,879 patients with type 2 diabetes. All three tirzepatide doses produced superior HbA1c reductions Tirzepatide versus Semaglutide Once Weekly
Pay in 4 interest-free payments of $5.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12




























![Lewmar V700 Fastening Kit 1 (Metric) [66000605] Communication | VHF - Handheld](https://cdn.shopify.com/s/files/1/1592/4149/products/95680XL.jpg?v=1663141626)